Cerebrospinal fluid proteins in idiopathic intracranial hypertension: An exploratory SWATH proteomics analysis

Proteomics Clin Appl. 2024 Jan;18(1):e2300021. doi: 10.1002/prca.202300021. Epub 2023 Aug 7.

Abstract

Purpose: The pathogenesis of idiopathic intracranial hypertension (IIH) is currently poorly understood. This exploratory study aimed to identify potential cerebrospinal fluid (CSF) biomarkers in IIH cases compared to controls using SWATH-MS proteomics approach.

Experimental design: CSF samples were collected prospectively from IIH cases and control subjects which were subjected to SWATH-MS based untargeted proteomics. Proteins with fold change > 1.5 or < 0.67 and p-value < 0.05 were considered significantly differentially expressed. Data are available via ProteomeXchange with identifier PXD027751. Statistical analysis was conducted in R version 3.6.2.

Results: We included CSF samples from 33 subjects, consisting of 13 IIH cases and 20 controls. A total of 262 proteins were identified in Proteinpilot search. Through SWATH analysis, we quantified 232 proteins. We observed 37 differentially expressed proteins between the two groups with 24 upregulated and 13 downregulated proteins. There were two differential proteins among overweight versus non-overweight IIH cases. Network for 23 proteins was highly connected in the interaction analysis.

Conclusions and clinical relevance: Neurosecretory, neuroendocrine, and inflammatory proteins were predominantly involved in causing IIH. This exploratory study served as a platform to identify 37 differentially expressed proteins in IIH and also showed significant differences between overweight and non-overweight IIH patients.

Keywords: SWATH-MS; biomarkers; cerebrospinal fluid; idiopathic intracranial hypertension; proteomics.

MeSH terms

  • Biomarkers / cerebrospinal fluid
  • Cerebrospinal Fluid Proteins
  • Humans
  • Overweight
  • Proteomics
  • Pseudotumor Cerebri* / cerebrospinal fluid

Substances

  • Cerebrospinal Fluid Proteins
  • Biomarkers